Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedMay 31, 2026
DataAggregated Company Financials
Companies6
  • 7D5.2%
  • 3M8.9%
  • 1Y-4.7%
  • YTD1.5%

The Life Sciences industry is up 5.2% in the last week, with SCHOTT Pharma KGaA up 7.2%. In contrast, the industry has lost 4.7% in the last 12 months. Looking forward, earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 31 May 2026€19.8b€7.5b€134.4m40.2x147.6x2.6x
Tue, 28 Apr 2026€17.7b€7.6b€231.8m35.5x76.4x2.3x
Thu, 26 Mar 2026€16.8b€7.5b€168.6m30.7x99.8x2.2x
Sat, 21 Feb 2026€19.2b€7.5b€168.3m30.2x114x2.5x
Mon, 19 Jan 2026€20.2b€7.5b€143.5m37.5x140.7x2.7x
Wed, 17 Dec 2025€18.9b€7.5b€143.5m40x131.9x2.5x
Fri, 14 Nov 2025€18.9b€7.5b€143.9m36.8x131.1x2.5x
Sun, 12 Oct 2025€18.6b€7.5b€117.9m42.5x158x2.5x
Tue, 09 Sep 2025€18.1b€7.4b€157.8m23x114.6x2.4x
Thu, 07 Aug 2025€17.5b€7.4b€107.0m24.2x163.1x2.4x
Sat, 05 Jul 2025€20.7b€7.3b€114.9m27.4x180.5x2.8x
Mon, 02 Jun 2025€21.0b€7.3b€114.9m29.1x182.5x2.9x
Wed, 30 Apr 2025€21.2b€7.3b€112.4m27.1x189x2.9x
Fri, 28 Mar 2025€20.9b€7.1b€156.5m27x133.8x2.9x
Sun, 23 Feb 2025€22.9b€7.1b€161.1m26.6x141.9x3.2x
Tue, 21 Jan 2025€22.3b€7.1b€169.8m25.5x131.1x3.1x
Thu, 19 Dec 2024€21.5b€7.1b€169.8m24.1x126.5x3x
Sat, 16 Nov 2024€21.8b€7.1b€170.5m26.5x127.8x3.1x
Mon, 14 Oct 2024€23.1b€7.1b€172.0m29.7x134.3x3.3x
Wed, 11 Sep 2024€25.4b€7.1b€172.8m34x146.8x3.6x
Fri, 09 Aug 2024€24.5b€7.0b€237.1m36.7x103.2x3.5x
Sun, 07 Jul 2024€24.4b€7.0b€309.8m35.2x78.9x3.5x
Tue, 04 Jun 2024€24.6b€7.0b€333.3m31.8x73.9x3.5x
Thu, 02 May 2024€28.5b€7.0b€340.1m37.5x83.8x4.1x
Sat, 30 Mar 2024€34.4b€7.1b€384.5m37.7x89.4x4.8x
Mon, 26 Feb 2024€33.2b€7.1b€378.2m37.9x87.7x4.7x
Wed, 24 Jan 2024€29.4b€7.3b€507.1m35.2x58x4x
Fri, 22 Dec 2023€32.6b€7.3b€507.1m34.6x64.3x4.5x
Sun, 19 Nov 2023€27.3b€7.3b€507.1m29.6x53.8x3.8x
Tue, 17 Oct 2023€23.4b€6.6b€498.8m35.5x47x3.5x
Thu, 14 Sep 2023€28.0b€6.6b€498.1m39.9x56.3x4.2x
Sat, 12 Aug 2023€30.0b€6.6b€425.8m43.6x70.5x4.6x
Mon, 10 Jul 2023€26.6b€6.8b€496.6m36.2x53.5x3.9x
Wed, 07 Jun 2023€28.9b€6.7b€487.3m40.2x59.3x4.3x
Price to Earnings Ratio

59.3x


Total Market Cap: €28.9bTotal Earnings: €487.3mTotal Revenue: €6.7bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 110.3x202420252026
Current Industry PE
  • Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 148x which is higher than its 3-year average PE of 110x.
  • The 3-year average PS ratio of 3.3x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 35% per year over the last three years.
  • Meanwhile revenues for these companies have grown 4.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market0.70%
Healthcare-0.51%
Life Sciences5.16%
Clinical Research and Equipment5.16%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1SXP SCHOTT Pharma KGaA€18.207.2%
+€183.7m
-36.1%PE19.2x
EVT Evotec€5.281.0%
+€8.9m
-24.1%PS1.3x
FA0 PExA€0.01812.3%
+€248.3k
4.0%PS4.6x

Latest News